Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 135.00
Bid: 135.20
Ask: 135.40
Change: 0.00 (0.00%)
Spread: 0.20 (0.148%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 135.00
KIE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Financial Officer

1 Aug 2019 07:00

RNS Number : 5174H
Kier Group PLC
01 August 2019
 

1 August 2019

 

 

 

Kier Group plc

 

Appointment of Chief Financial Officer

Kier Group plc ("Kier" or the "Company") announces that Simon Kesterton will be appointed to its board of directors (the "Board") as Chief Financial Officer Designate with effect from 26 August 2019 and will assume the role of Chief Financial Officer from 19 September 2019.

 

Bev Dew, Kier's Finance Director, will stand down from the Board immediately following the announcement of the Company's results for the 2019 financial year and is expected to remain on garden leave for the remainder of his notice period, which concludes in May 2020.

 

From 2013 to 31 July 2019, Mr. Kesterton was Group Finance Director at RPC Group plc. Prior to this, he was Chief Financial Officer, Europe and also Chief Strategic Officer at IAC Group, where he worked from 2006 to 2012. During the early part of his career, Mr. Kesterton undertook a number of finance roles at Collins & Aikman and British Federal.

 

Andrew Davies, Chief Executive of Kier, said: "Simon has a broad range of finance experience across a number of sectors. In particular, he has played a key role in implementing programmes which focus on the disposal of non-core assets, the reduction of overheads and cost control. I would like to welcome Simon to Kier and I look forward to working with him."

 

- ENDS -

 

 

For further information, please contact: 

 

Cynthia Alers, Investor Relations

Kier Press Office 

+44 (0)20 3208 6059

+44 (0)1767 355 096

Richard Mountain/Nick Hasell, FTI Consulting 

+44 (0)20 3727 1340

 

The Company confirms that there are no other disclosures to be made in connection with Mr. Kesterton's appointment under LR 9.6.13R of the Listing Rules.

 

This announcement contains inside information for the purposes of Market Abuse Regulation (Regulation (EU) No. 596/2014). The person responsible for making this announcement on behalf of the Company is Hugh Raven, General Counsel and Company Secretary.

 

This announcement does not constitute an offer of securities by Kier Group plc (the "Company" and, together with its subsidiaries, the "Group"). This announcement may include statements that are, or may be deemed to be, ''forward-looking statements''. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond the Company's or the Group's ability to control or predict. Forward-looking statements are not guarantees of future performance. You are advised to read the section headed ''Principal risks and uncertainties'' in the Company's Annual Report and Accounts for the year ended 30 June 2018 and the section of the Company's rights issue prospectus dated 30 November 2018 entitled "Risk factors" for a further discussion of the factors that could affect the Company's or the Group's future performance and the industry in which it operates. Other than in accordance with its legal or regulatory obligations, the Company does not accept any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOACKDDKPBKKDFK
Date   Source Headline
17th Apr 202412:30 pmRNSDirector/PDMR Shareholding
8th Apr 202411:26 amRNSDirector/PDMR Shareholding
5th Apr 202410:15 amRNSDirector/PDMR Shareholding
2nd Apr 20243:19 pmRNSDirector/PDMR Shareholding
2nd Apr 20241:00 pmRNSTotal Voting Rights
20th Mar 20245:48 pmRNSDirector/PDMR Shareholding
19th Mar 202410:12 amRNSDirector/PDMR Shareholding
15th Mar 20248:40 amRNSPost Stabilisation Notice
11th Mar 202410:37 amRNSBlock Listing Application
7th Mar 20247:00 amRNSResults for the period ended 31 December 2023
1st Mar 202410:11 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSGreen Economy Mark and SBTi certifications
20th Feb 20241:43 pmRNSDirector/PDMR Shareholding
15th Feb 202411:05 amRNSKier Group plc successfully issues Senior Notes
15th Feb 202410:09 amRNSHolding(s) in Company
8th Feb 20245:22 pmRNSKier Group plc Announces Pricing of Senior Notes
6th Feb 202410:59 amRNSPre Stabilisation Notice
5th Feb 20248:03 amRNSKier Announces Proposed Offer of Senior Notes
1st Feb 20242:16 pmRNSTotal Voting Rights
22nd Jan 202410:30 amRNSDirector/PDMR Shareholding
18th Jan 20247:00 amRNSTrading Update
5th Jan 202411:47 amRNSHolding(s) in Company
2nd Jan 20243:44 pmRNSBlock listing Interim Review
2nd Jan 20243:42 pmRNSTotal Voting Rights
27th Dec 202310:10 amRNSReduction of Capital
27th Dec 202310:05 amRNSHolding(s) in Company
27th Dec 202310:02 amRNSHolding(s) in Company
21st Dec 202312:21 pmRNSDirector/PDMR Shareholding
19th Dec 20233:57 pmRNSDirector/PDMR Shareholding
18th Dec 20234:50 pmRNSDirector/PDMR Shareholding
14th Dec 202310:35 amRNSDirectorate Change
1st Dec 202310:53 amRNSTotal Voting Rights
22nd Nov 202311:09 amRNSDirector/PDMR Shareholding
20th Nov 20233:10 pmRNSDirector/PDMR Shareholding
16th Nov 20234:00 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Trading Update
1st Nov 202312:28 pmRNSTotal Voting Rights
1st Nov 202312:24 pmRNSDirector/PDMR Shareholding
30th Oct 20234:00 pmRNSDirector/PDMR Shareholding
24th Oct 20239:37 amRNSHolding(s) in Company
20th Oct 202312:00 pmRNSDirector/PDMR Shareholding
10th Oct 202310:09 amRNSHolding(s) in Company
6th Oct 20232:34 pmRNSAnnual Financial Report
2nd Oct 202311:15 amRNSTotal Voting Rights
22nd Sep 20232:00 pmRNSDirector/PDMR Shareholding
22nd Sep 202310:09 amRNSHolding(s) in Company
20th Sep 20231:42 pmRNSHolding(s) in Company
20th Sep 20231:39 pmRNSDirector/PDMR Shareholding
15th Sep 20234:06 pmRNSDirector/PDMR Shareholding
14th Sep 20232:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.